Skip to main content
Vilcek Foundation
  • About
    • About

      The Vilcek Foundation raises awareness of immigrant contributions in the United States and fosters appreciation of the arts and sciences.

    • Our Mission
    • Our Founders
    • Board & Staff
    • Press Center
    • Contact
  • Prizes
    • Prizes

      The Vilcek Foundation Prizes are awarded to foreign-born individuals for extraordinary achievement in the arts and sciences.

    • About the Prizes

      Learn more about the Vilcek Foundation Prizes and the prizewinners.

    • Vilcek Prizes

      Awarded to immigrants with a legacy of major accomplishments.

    • Vilcek Prizes for Creative Promise

      Awarded to young immigrant professionals who have demonstrated outstanding achievement early in their careers.

    • Vilcek Prize for Excellence

      Awarded to immigrants who have had a significant impact on American society, or to individuals who are dedicated champions of immigrant causes.

    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
Sign Up Search
Home > News > Katalin Karikó Wins a 2022 Breakthrough Prize in Life Sciences

Katalin Karikó Wins a 2022 Breakthrough Prize in Life Sciences

News | May 2, 2023
Tags
biotechnology breakthrough prize covid-19 messenger rna mRNA rna vilcek prize for excellence
Download audio
Audio: Listen to this post
Share this page
Twitter Facebook LinkedIn

Hungarian Scientist and 2022 Vilcek Prize Recipient Is Honored for mRNA Vaccine Breakthrough

Trailblazing biochemist Katalin Karikó was honored with a 2022 Breakthrough Prize in Life Sciences for her pioneering work in modifying messenger RNA–based technology. Her research paved the way for the swift development of COVID-19 vaccines. She had previously received the 2022 Vilcek Prize for Excellence in Biotechnology.

Although Karikó is now widely celebrated for her groundbreaking contributions to mRNA research, her journey has been far from smooth. The native of Hungary has been living and working in the United States since 1985. During the ’90s, she faced numerous rejections after her work on utilizing mRNA to combat diseases was deemed too unconventional to receive funding from government grants, corporations—and even her peers.

The Fight Against COVID-19

At the outset of her scientific career, Karikó was part of an innovative clinical trial involving double-stranded RNA (dsRNA) to treat patients with hematologic diseases, AIDS, and chronic fatigue syndrome. Her research eventually led her to the University of Pennsylvania, where she worked on messenger RNA (mRNA) with cardiologist Elliot Barnathan, whose experiments demonstrated that mRNA could be used to produce human proteins.

Karikó believed that if mRNA could be engineered to encode specific proteins and introduced to humans, it could revolutionize disease treatment. However, two obstacles stood in the way: Synthetic mRNA injections triggered an immune response, and funding in this field was limited.

A young Katalin Karikó in a white lab coat working in the lab.
Photo courtesy of Katalin Karikó

In 1990, Karikó applied for a grant and proposed developing mRNA gene therapy. Despite being demoted in 1995 due to grant rejections, she persevered and eventually met immunologist and professor Drew Weissman at the University of Pennsylvania, with whom she worked on mRNA technology.

In 2005, while working alongside Weissman, Karikó found out that mRNA-based modified nucleosides eliminated inflammatory properties, making them safe when used for medical purposes. The duo later obtained patents for their work on modified nucleosides, however, the university eventually sold the intellectual property to the head of a lab supply company (now known as Cellscript).

In 2006, Karikó teamed up with biochemist Ian MacLachlan to further work on mRNA technology, and in 2013 she left the university to join the German company BioNTech RNA Pharmaceuticals as a senior vice president.

Upon the release of the gene sequence of the coronavirus in early 2020, biotech companies realized that mRNA technology could target the unique spike protein found in the virus. Leveraging Karikó’s decades of research, BioNTech developed the world’s first mRNA-based vaccine to fight the COVID-19 pandemic.

Well-Deserved Recognition

Over the past two years alone, Karikó’s groundbreaking work has earned her over 110 accolades, including the Breakthrough Prize in Life Sciences in 2022, the 2022 Vilcek Prize for Excellence for pioneering vaccine research, and the European Inventor Award 2022 for “Lifetime Achievement”—one of Europe’s most prestigious innovation prizes.

In Hungary, she is revered as a national hero. A large mural on a building in Budapest depicts a portrait of her with the message “Hungarians build the future.” She was also a top contender for the Nobel Prize in both 2021 and 2022, although she was not awarded the prize in either year.

Embed from Getty Images

In 2022, during an interview with a Hungarian magazine, she announced that she would be departing from her position as senior vice president at BioNTech. Although she did not disclose her next workplace, she expressed the desire to once again focus on her scientific work, which had been sidelined for the past year and a half due to other commitments.

Karikó firmly believes that passion, single-minded focus, and a sense of mission are essential ingredients for fulfillment in the field of science. In the future, she hopes to use her platform to inspire the next generation of scientific leaders, to encourage research funding, and to continue to promote science for the advancement of humankind.

Tags
biotechnology breakthrough prize covid-19 messenger rna mRNA rna vilcek prize for excellence
Share this page
Twitter Facebook LinkedIn

Related News

March 29, 2022

Katalin Karikó: The sacrifices and successes of immigrant scientists

Amid multiple awards for the development of mRNA vaccines, Hungarian biochemist Katalin Karikó insists that her greatest success has been being able to show up every day for a career she is passionate about.
Katalin Karikó standing in the woods in a beige coat with fur trim.
June 8, 2021

Vilcek Foundation awards $100,000 prize to Dr. Katalin Karikó, immigrant scientist who pioneered mRNA vaccine technology

Dr. Katalin Karikó receives the 2022 Vilcek Prize for Excellence in Biotechnology.
Katalin Karikó sits in her home office dressed in a black blazer.
June 8, 2021

Dr. Katalin Karikó receives 2022 Vilcek Prize for Excellence for pioneering vaccine research

The 2022 Vilcek Prize for Excellence in Biotechnology is awarded to Dr. Katalin Karikó for her research discoveries that rendered mRNA vaccines for COVID-19 possible.

You may also be interested in

Katalin Karikó

Katalin Karikó receives the Vilcek Prize for Excellence in Biotechnology for her pioneering research leadership into the development of mRNA therapeutics, which led to the development of mRNA vaccines for COVID-19.
Portrait of Katalin Karikó

Harris Wang

Harris Wang receives the Vilcek Prize for Creative Promise in Biomedical Science for the development and application of Mutiplex Automated Genome Engineering (MAGE), a platform to track, program, and engineer entire microbial communities and ecosystems for a range of diagnostic and therapeutic applications.
Portrait of Harris Wang

Silvi Rouskin

Silvi Rouskin receives the Vilcek Prize for Creative Promise in Biomedical Science for developing methods to unravel the shapes of RNA molecules inside cells and aiding the potential development of RNA-based therapeutics.
Portrait of Silvi Rouskin

Join our mailing list

Sign Up
Vilcek Foundation
21 East 70th Street
New York, New York 10021

Phone: 212.472.2500

Email: info@vilcek.org

  • About
    • Our Mission
    • Our Founders
    • Board and Staff
    • Press Center
    • Contact
  • Prizes
    • Vilcek Prizes
    • Vilcek Prizes for Creative Promise
    • Vilcek Prize for Excellence
    • Prize Recipients
    • Grants for Organizations
  • Art
  • Events
  • News
  • Careers
Connect with us
  • Facebook
  • Instagram
  • Twitter
  • LinkedIn
  • Youtube
  • Vimeo
  • Privacy Policy
  • Accessibility Statement
© 2023   Vilcek Foundation